Traditional Chinese medicine composition for treating hepatorenal syndrome caused by liver-yang hyperactivity

Abstract

The invention relates to the technical field of medicines, and in particular relates to a traditional Chinese medicine composition for treating hepatorenal syndrome caused by liver-yang hyperactivity. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicines in parts by weight: 5-13 parts of turtle shell, 4-8 parts of olive shell, 4-8 parts of delonix regia, 4-8 parts of cynanchum auriculatum, 4-8 parts of shrubberry rhodiola roots, 4-8 parts of rubus hirsutus, 4-8 parts of gymnadenia conopsea, 4-8 parts of elatostema myrtillus and 4-8 parts of liquorice. A plurality of medicines work together to reach the efficacies of tonifying the liver and kidneys, and nourishing the yin and suppressing yang, and the traditional Chinese medicine composition is capable of effectively improving the clinical symptoms and the signs of patients, reducing blood urea nitrogen, creatinine and urine protein level, improving the glomerular filtration rate, improving the kidney function, lowering the glutamic-pyruvic transaminase and glutamic oxalacetic transaminase levels and improving the liver function.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a traditional Chinese medicine composition for treating liver-yang hyperactivity type hepatorenal syndrome. Background technique [0002] Hepatorenal syndrome (HRS) refers to a functional renal failure in patients with severe liver diseases such as cirrhosis and severe viral hepatitis without clear primary renal disease. It was first proposed by Helwig in 1932. At that time, it was used to describe acute renal failure after biliary obstruction surgery. Later, it was used to refer to all diseases involving the liver and kidney at the same time. At present, it often refers to liver cirrhosis, fulminant hepatic failure, severe viral hepatitis, primary Functional renal failure secondary to severe liver disease such as primary or secondary liver cancer. There are no primary and specific organic lesions in the kidneys of patients with hepatorenal syndrome, and there are n...

AI Technical Summary

Problems solved by technology

At present, the pathogenesis of hepatorenal syndrome is not fully understood by Western medicine, and there is no effective treatment for it.